OVERVIEW

Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking EP 199 is organized by Pri-Med.

Release Date: 11/23/2020
Expiration Date: 11/23/2021

Accreditation:
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Topics: Urology

Overview:
Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.

Learning Objectives:
• Assess the risk for malignancy in patients with microhematuria
• Describe a risk-based approach to evaluating microhematuria

Additional details will be posted as soon as information is available.